Skip to content

Sionna Therapeutics, Inc.

SION

CIK 0002036042 · Pharmaceutical Preparations · Nasdaq

← back to feed
Revenue (TTM)
—
Q1 Apr 2026
Net Income (TTM)
−$81.61M
−22.0% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$411.68
+88.2% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
−$66.67M
Q1 Apr 2026
Cash
$63.32M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
45.15M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings